Search

Search Constraints

You searched for: Author/Creator Rubin, David T

Search Results

71. Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction. Issue 3 (13th July 2021)

72. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials. Issue 10340 (28th May 2022)

73. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial. Issue 10340 (28th May 2022)

74. Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab. (September 2017)

77. SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting. Issue 4 (20th January 2021)

80. Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin. Issue 2 (26th October 2015)